Associate Medical Director

Scorpion Therapeutics; Watertown (MA); On-site; USD 231,000 - 255,000; Full time

Job summary

Scorpion Therapeutics in Watertown, MA seeks an MD with clinical research experience to drive oncology development programs from Phase I to pivotal studies. You will collaborate with cross-functional teams to shape clinical strategy and act as medical monitor for relapsed/refractory multiple myeloma trials, ensuring patient safety and high-quality data.

The role requires strategic thinking, strong communication, and ability to navigate a fast-paced matrix environment while engaging investigators

Qualifications

• MD (or internationally recognized equivalent) with ≥1 year in pharma/CRO/academic clinical research.
• Ability to balance strategic vision with hands-on execution.
• Excellent scientific communication and stakeholder alignment.
• Strong interpersonal/negotiating skills; diplomacy to drive decisions.
• Strong analytical skills with attention to detail.

Responsibilities

• Drive oncology development programs by refining clinical study protocols from Phase I through pivotal studies.
• Collaborate with cross-functional teams to align on clinical strategy and study design.
• Serve as medical monitor for relapsed/refractory multiple myeloma trials, ensuring safety and data quality.
• Guide recruitment, study conduct, and dosing signals appropriate to trial stage.
• Assess overall safety information in collaboration with Pharmacovigilance.
• Develop relationships with key opinion leaders, investigators, and sites.
• Support global regulatory filings input (IB sections, INDs, CTAs, NDAs).
• Engage investigators; support site initiation visits and investigator meetings.
• Assist Pharmacovigilance with data review for patient safety.

Skills

Clinical research

Scientific communication

Stakeholder alignment

Analytical mindset

Education

MD or international equivalent

Job description

Your Role / Responsibilities:

• Drive oncology development programs by refining clinical study protocols from Phase I through pivotal studies supporting regulatory submissions.
• Collaborate with cross-functional teams (Clinical Operations, Regulatory Affairs, Biostatistics) to align on clinical strategy and study design.
• Serve as medical monitor for assigned relapsed refractory multiple myeloma clinical trials, providing medical oversight, addressing protocol conduct and subject safety issues to ensure timely, high-quality data.
• Guide recruitment, study conduct, and dose escalation/early signals of activity appropriate to trial stage.
• Assess overall safety information for studies/compound with Pharmacovigilance.
• Develop and maintain relationships with key opinion leaders, investigators, and clinical trial sites.
• With the Senior Medical Director, provide input to global regulatory filings (IB clinical sections, INDs, CTAs, NDAs).
• Engage academic investigators; support site initiation visits and lead investigator meetings.
• Assist Pharmacovigilance with reviewing/interpreting clinical data for accuracy, context, and patient safety.
• Represent C4T in the scientific community; contribute to publication plans and build external expert relationships.

Required:

• M.D. (or internationally recognized equivalent) and at least 1 year of clinical research experience in pharma/CRO/consulting or academia.
• Ability to balance strategic vision with hands-on execution; work collaboratively in a fast-paced matrix and independently as needed.
• Exceptional scientific communication; active listening and stakeholder alignment.
• Strong interpersonal/negotiating skills; proactive issue prediction and decision-driving via diplomacy.
• Strong analytical/problem-solving skills with attention to detail.

Preferred:

• Clinical development experience (biotech/pharma), including companion diagnostics, clinical operations, and pharmacovigilance.
• Oncology and/or hematology experience (practice or life sciences).

Compensation:

Base pay range: $230,938.00–$255,245.00 annually (varies by factors such as knowledge, skills, experience).